An introduction to the JLA. What will I cover? What is the James Lind Alliance (JLA)? What do we do? How do we do it? What difference does it make?

Slides:



Advertisements
Similar presentations
The Cochrane Library. What is The Cochrane Library? The Cochrane Library offers high-quality evidence for health care decision making
Advertisements

Case studies: Identifying the treatment uncertainties of people with asthma & their clinicians Colin Gelder Asthma Editor DUETs.
UK Clinical Research Network (UKCRN) UK Clinical Research Network Maxine Stead PhD UKCRN Assistant Director – Clinical Trials.
Avoiding waste in research: the role of public involvement Iain Chalmers Coordinator James Lind Initiative NCRN Consumer Liaison Group Meeting Leeds, 25.
Meaningful Patient Involvement In FP7 Research Nicola Bedlington Meaningful Patient Involvement In FP7 Research Nicola Bedlington Open Information Day.
1. Choosing outcomes and measures - for doing and using research James Lind Alliance Outcomes in clinical research – whose responsibility? 20 November.
1 Developing an effective system of service user and carer involvement in research School of Health and Social Care University of the West of England Jane.
Rudi Page Church of God of Prophecy UK Community Partners for Reverse Commissioning September 2011.
The James Lind Alliance ….. the story so far. NICE Conference Tackling Health Priorities 7 th December 2006.
Life after Stroke in Scotland Nursing, Midwifery and Allied Health Professions Research Unit.
Avoiding waste in research: the role of public involvement Iain Chalmers Coordinator, James Lind Initiative ‘Putting people first in research’ INVOLVE.
The James Lind Alliance Tackling treatment uncertainties together Lester Firkins, John Scadding and Mark Fenton INVOLVE Conference 2006.
The Key Role of Charities in Supporting Brain Research Marie Downes, MRCG Development Executive Brain Research in Ireland: Delivering on the Potential.
Cochrane Agenda and Priority Setting Methods Group (CAPSMG)
Janet Darbyshire (25 June 07) UK Clinical Research Network (UKCRN) Identifying research priorities in the UK Clinical Research Network.
Why we need to get to grips with alcohol in Wessex.
The Cochrane Collaboration’s Prioritization Approaches Lorne Becker: Co-Chair, Cochrane Collaboration Steering Group US Cochrane Center Conference on Priority.
Evidence Aid: A resource for those preparing for and responding to natural disasters, humanitarian crises and major healthcare emergencies Claire Allen.
Standards Debate at the Centre for Better Managed Health Care, Cass Business School, City University London, 26 th October Professor Mike Kelly Director.
1 Integration to avoid hospital admission: ITHAcA Sarah Purdy on behalf of the HIT.
Access to Clinical Expertise Steve Bain David Powell Jemma Hughes Paula Jeffries.
Professor Ken Stein Professor of Public Health University of Exeter Medical School (UEMS)
Building Research Capacity for Community Organizations: Strategies from the Alliance for Research in Chicagoland Communities Ben Rucker MPH, 1,2 Sherida.
An introduction to the JLA Katherine Cowan. What will I cover? What is the James Lind Alliance (JLA)? What do we do? How do we do it? What difference.
Live well with Dementia: an achievable goal Age UK Brent Conference Carolyn Denne October 2013.
James Lind Alliance Working Partnership on Urinary Incontinence.
The Patient Safety Collaborative Programme World Stop Pressure Ulcers Day Fiona Thow 20 November 2014Network.
Welcome to SURF 09 Involving Patients and the Public in HCAI Research.
Public and patient priorities for research: an international perspective Astrid van der Schot Marco Blom Alzheimer Nederland Glenn Rees Ellen Skladzien.
Simon Wills Head of Wessex Drug & Medicines Information Centre Introduction Research is needed to help inform service development and to demonstrate the.
Pressure 1h How is new technology helping to achieve the James Lind Alliance’s mission? #tacklingtreatmentstogether ExpandReply Delete Favourite.
The South East Wales Academic Health Science Partnership Dr Corinne Squire Manager SEWAHSP.
Our Plans for 2015/16 We want to make sure that people in our area are able to live long and healthy lives, both now and in the future, and our plans set.
The European Innovation Partnership for asthma: an opportunity for change Samantha Walker PhD, Asthma UK Project Coordinator, EARIP (European Asthma Research.
New DFE Statutory Guidance and OFSTED Changes statutory-guidancewww.education.gov.uk/aboutdfe/statutory/g /sure-start-
Evaluation, Trials and Studies Coordinating Centre Developing Sight Loss and Vision research questions: a funder’s perspective Anna Tallant Scientific.
James Lind Alliance Tackling treatment uncertainties together James Lind,
James Lind Initiative Database of Uncertainties about the Effects of Treatments (DUETs) what gaps in the evidence matter to patients and doctors? Iain.
Network of Hubs for Trials Methodology Research Mike Clarke, Chair.
Open to all: the role of public involvement in health research Faculty of Health and Social Care, Open University, Wednesday 9 th December 2015 Simon Denegri,
NIHR Themed Call Prevention and treatment of obesity Writing a good application and the role of the RDS 19 th January 2016.
Patient and public involvement (PPI) in setting the research agenda Dr Noémi Roy Oxford Molecular Haematology.
Evaluation, Trials and Studies Coordinating Centre NIHR funded research NIHR Research Professor Professor Ashley Adamson.
R&D Report to SL&M Board 17 September 2002 Graham Thornicroft Director of Research & Development Gill Dale Research & Development Manager.
EoE Respiratory Strategic Clinical Network Progress so far…. Lianne Jongepier RSCN Manager 17 th July 2014.
NIHR Southampton Biomedical Research Centre The Southampton Biomedical Research Centre is funded by the National Institute for Health Research (NIHR) and.
Cochrane Agenda and Priority Setting Methods Group (CAPSMG)
Defining future research priorities: Results of the UK Kidney Transplant Priority Setting Partnership Simon Knight Academic.
Patient, Carer and Public Involvement and Engagement in Anaesthesia Research National Institute for Academic Anaesthesia Health Services Research Centre.
Research Networks – opportunities for SLTs Dr Caroline Pickstone, Senior Manager, SY CLRN.
Trusted evidence. Informed decisions. Better health. The Cochrane Tobacco Addiction Group at 20: ensuring our evidence is relevant Dr Nicola Lindson-Hawley.
The James Lind Alliance
Engaging and Supporting Surgical Research: Clinical Research Networks
Your Symptoms Matter – Prostate Cancer
Hematopoietic Cell Transplantation: Moving Beyond Survival to the Patient’s Perspective Linda J Burns, MD Medical Director, NMDP/Be The Match Health.
Ageing Better Programme
Dr Joe McNamara Head of Population Health Sciences MRC
@hrbtmrn Intro and welcome.
Research for all Sharing good practice in research management
Cochrane Skin Prioritisation Project
Sight Loss and Vision Priority Setting Partnership
Improving Outcomes by Helping People Take Control
Rachel Taylor, Ana Martins, Sarah Lea, Jeremy Whelan, Lorna Fern
Ten Key Trials in Cardiovascular Surgery
Role & Relevance of Cochrane UK to trainees
An Introduction to the NIHR programmes
A brief introduction to the James Lind Alliance
Assignment 2 Learning Aim D: Individual Treatment Plan
Vision Strategy Transition Programme
Supporting Priority Setting Partnerships
Presentation transcript:

An introduction to the JLA

What will I cover? What is the James Lind Alliance (JLA)? What do we do? How do we do it? What difference does it make?

What is the James Lind Alliance? A small initiative – four part-timers Funded by the National Institute for Health Research Established in 2004

What is the James Lind Alliance? Tackling treatment uncertainties together Finding out what research is important to: Patients / service users Carers Clinicians / healthcare professionals

What is the James Lind Alliance? Why patients, carers and clinicians?

What do we do? Priority Setting Partnerships Patients, carers and clinicians Focusing on single conditions Identifying uncertainties about treatments Prioritising the ones they think are most important for research to address A top 10

What do we do? Completed PartnershipsCurrent Partnerships Asthma Urinary incontinence Vitiligo Prostate cancer Schizophrenia Type 1 diabetes ENT aspects of balance Stroke Eczema Cleft lip and palate Dementia Head and neck cancer Lyme disease Pressure ulcers Pre-term birth Sight loss and vision Tinnitus

How do we do it? The priority setting process: Set up steering group Invite partners Gather uncertainties Prioritise uncertainties Promote priorities to researchers and funders

How do we do it? Set up steering group Patient, carer and clinician representatives Resources and expertise Protocol

How do we do it? Invite partners Patients, carers, clinicians and their representatives Declaration of interests Affiliation Exclusions

How do we do it? Gather uncertainties no up-to-date, reliable systematic reviews of research evidence addressing the uncertainty about the effects of treatment exists up-to-date systematic reviews of research evidence show that uncertainty exists

How do we do it? Gather uncertainties Survey Research recommendations UK Database of Uncertainties about the Effects of Treatments (UK DUETs)

How do we do it? Prioritise uncertainties – step 1 (interim stage) From a long list to a short list Top 10 uncertainties chosen by partners

How do we do it? Prioritise uncertainties – step 2 (final) Priority setting workshop Patients, carers and clinicians A day of democratic discussion and ranking Prioritise the remaining uncertainties Agree the top 10

How do we do it? Promote priorities to researchers and funders NIHR Health Technology Assessment programme Dissemination of findings

What difference does it make? Asthma Funding has been awarded to research to provide better evidence on the effects of breathing exercises for asthma.

What difference does it make? Urinary Incontinence Five related studies have been funded and several more are in development, addressing six of the top 10 priorities, with two combined.

What difference does it make? Vitiligo A pharmaceutical company is preparing to run a pilot multi-centre trial on number 6 of the top 10. The Centre of Evidence Based Dermatology is developing two research ideas from the top 10 into a trial protocol.

What difference does it make? Prostate cancer The prioritised list has informed the research funding strategies of Prostate Action and the Prostate Cancer Charity. Over 15 projects addressing the priorities have been funded since the workshop in October 2010.

Get involved! Contribute personal experience and professional expertise. Collaborate with different groups. Help to shape the research agenda.

For more information… – become an Affiliate – practical guidance Thank you!